Evidence map›Paper›PMID 42138940›Full record

ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Mechanisms of Pericyte-Mediated Cancer Metastasis.

Ziheng Guo, Yihai Cao

Abstract readReview
In one paragraph

Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Impact ofOncology research · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ziheng GuoDepartment of Pancreatic Surgery, West China Hospital, Sichuan University, Chengdu, China.
Yihai CaoDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0003-1308-0065

Funding

Hong Kong Centre for Cerebro-Cardiovascular Health EngineeringHorizon Europe grant-PERSEUS 101099423NOVO Nordisk Foundation, the Swedish Research Council 2016-02215NOVO Nordisk Foundation, the Swedish Research Council 2019-01502NOVO Nordisk Foundation, the Swedish Research Council 2021-06122Swedish Cancer Foundation
6 · The paper itself

Abstract

Emerging experimental evidence shows that perivascular cells (PCs), referred to as pericytes lying within the basement membrane (BM) and surrounding endothelial cells (ECs) of microvasculatures, play multifarious roles in cancer metastasis. In the tumor microenvironment (TME), PC detachment and ablation from tumor microvessels obliterate the vascular integrity and the protective barrier of the vessel wall, leading to increased permeability for cancer cell intravasation. PCs retain mesenchymal stem cell (MSC) features and commit to differentiation into other stromal cells, including the pericyte-fibroblast transition (PFT) for promoting cancer metastasis. Activated PCs produce a myriad of growth factors, cytokines, and chemokines, which promote invasiveness and dissemination of cancer cells by altering tumor angiogenic, inflammatory, and immune microenvironment. Owing to their high lineage and phenotypic plasticity, PCs significantly constitute to the pre-metastatic niche formation in distal organs. This review provides an updated overview and mechanistic insights into each of PC-mediated critical processes of the metastatic cascade.

Indexed as

Neoplasm MetastasisNeoplasmsPericytesTumor MicroenvironmentAnimalsEndothelial CellsHumansMesenchymal Stem CellsNeovascularization, PathologiccancermetastasisPericytetumor microenvironmenttumor vasculature

Identifiers

PMID42138940
PMCPMC13271616

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.